This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Venkata Durga Nageswar Yadavalli: Innovator in Hypoglycemic Agents
Introduction
Venkata Durga Nageswar Yadavalli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypoglycemic agents. His innovative work aims to address critical health issues, such as diabetes, through novel chemical compounds.
Latest Patents
Yadavalli holds a patent for his invention titled "1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines, process for preparation thereof and use thereof as hypoglycemic agents." This patent describes a process for synthesizing 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines, which are identified as potential new hypoglycemic agents. The invention is particularly relevant for the treatment of diabetes, showcasing Yadavalli's commitment to improving health outcomes.
Career Highlights
Yadavalli is associated with the Council of Scientific and Industrial Research, where he engages in research and development activities. His work focuses on creating innovative solutions that can lead to better management of diabetes and related health conditions. His dedication to scientific research has positioned him as a valuable contributor in his field.
Collaborations
Yadavalli collaborates with esteemed colleagues, including Ramalingam Thallapalli and Ramakrishna Sistla. These partnerships enhance the research environment and foster innovation in the development of new therapeutic agents.
Conclusion
Venkata Durga Nageswar Yadavalli exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of hypoglycemic agents, reflect his dedication to advancing medical science and improving patient care. His work continues to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
